{"id":"NCT02104830","sponsor":"Biocad","briefTitle":"Study of the Efficacy and Safety of Empegfilgrastim for Neutropenia Prophylaxis in Breast Cancer Patients","officialTitle":"Multicenter Randomized Double-blind Phase III Clinical Study Comparing the Efficacy and Safety of a Single Dose Extimia® Versus Daily Filgrastim for Neutropenia Prophylaxis in Breast Cancer Patients Receiving Myelosuppressive Chemotherapy","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2013-09","primaryCompletion":"2014-06","completion":"2014-10","firstPosted":"2014-04-04","resultsPosted":"2016-10-24","lastUpdate":"2016-10-24"},"enrollment":135,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"SUPPORTIVE_CARE"},"conditions":["Chemotherapy-induced Neutropenia"],"interventions":[{"type":"BIOLOGICAL","name":"Empegfilrastim 6 mg","otherNames":["Extimia","metpegfilgrastim","pegylated filgrastim","peg-GCSF"]},{"type":"BIOLOGICAL","name":"Filgrastim","otherNames":["GCSF"]},{"type":"BIOLOGICAL","name":"Placebo №1","otherNames":[]},{"type":"BIOLOGICAL","name":"Placebo №2","otherNames":[]},{"type":"BIOLOGICAL","name":"Empegfilrastim 7.5 mg","otherNames":["Extimia","metpegfilgrastim","pegylated filgrastim","peg-GCSF"]}],"arms":[{"label":"Empegfilgrastim 6 mg","type":"EXPERIMENTAL"},{"label":"Empegfilgrastim 7.5 mg","type":"EXPERIMENTAL"},{"label":"Filgrastim","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of the study is to compare safety and efficacy of a single dose of empegfilgrastim and daily dosing of filgrastim for prevention of neutropenia in patients receiving AT (docetaxel 75 mg/m2 + doxorubicin 50 mg/m2).","primaryOutcome":{"measure":"Duration of Neutropenia CTCAE Grade 4","timeFrame":"3 weeks","effectByArm":[{"arm":"Empegfilgrastim 6 mg","deltaMin":0.905,"sd":1.206},{"arm":"Empegfilgrastim 7.5 mg","deltaMin":0.791,"sd":1.013},{"arm":"Filgrastim","deltaMin":1.725,"sd":1.519}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"FEMALE","healthyVolunteers":false,"inclusionCount":19,"exclusionCount":15},"locations":{"siteCount":13,"countries":["Russia"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":42},"commonTop":["Leucopenia","neutropenia any grade","Weakness / asthenia","Anemia","Hyperglycemia"]}}